[Taylor&Francis] First-line concomitant EGFR-TKI + chemotherapy versus EGFR-TKI alone for advancedEGFR-mutated NSCLC: a meta-analysis of randomized phase III trials

fahad1425 Post time The day before yesterday 22:03 | Show all posts |Read mode
This post will be closed automatically in 2026-07-01 22:00
Reward70points

journalㄩExpert Review of Anticancer Therapy

AuthorsㄩThierry Landre; Jean-Baptiste Assi谷; Kader Chouahnia; Gaetan Des Guetz; Jean-Bernard Auliac; Christos Chouad

Published dateㄩ2024-8-2

DOIㄩ10.1080/14737140.2024.2362889

PDF linkㄩhttps://www.tandfonline.com/doi/pdf/10.1080/14737140.2024.2362889

Article linkㄩhttps://doi.org/10.1080/14737140.2024.2362889

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
aellie Post time The day before yesterday 22:03 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list